Key Product Detail – Yssels

Yssel’s Serum Free T-Cell Medium

Yssel’s Serum Free T-Cell Medium

Yssel’s Serum-Free T-Cell Media enables advanced therapy researchers and developers to streamline their workflow process, allowing them to bring their end products to market quickly by providing a T-Cell media that is manufactured under cGMP, is serum free, and can be custom manufactured to meet customer’s unique needs.


T-Cell media that meets the needs of cell therapy researchers and developers.


For the cell culture of T-Cells where stringent regulatory requirements must be met, GeminiBio offers Yssel’s Serum Free T-Cell Media.  Yssel’s media was developed specifically for human T cell growth and includes xeno free and phenol red free options.  Custom manufacturing is available to optimize package size and type to optimize customer’s development or production workflows.

Yssel’s Serum Free T-Cell Media

Catalog No. 900-134 900-106 900-103 900-102
Xeno Free Yes Yes No No
Phenol Red Free Yes No Yes No

Yssel’s Serum Free Media Portfolio 

No results found :(

Our Integrated Quality Approach


Certifications, Registrations and Compliance01

To meet the stringent quality requirements of our customers, GeminiBio is certified to ISO 13485:2016, maintains an FDA registration under Class I Medical Devices, and is aligned with 21 CFR Part 820: Quality System Regulation.


Learn More
Certifications Registrations and Compliance

Manufacturing Design02

GeminiBio’s facilities are designed with current Good Manufacturing Practices (cGMP) and our customer’s quality requirements in mind. Our animal origin free (AOF) manufacturing facility is 1/4 mile away from our animal origin (AO) manufacturing facility. In addition, our cGMP warehouse is designed with flows for both personnel and materials, including segregation of AO and AOF materials.


Learn More
Manufacturing Design

Risk Management03

GeminiBio has developed a robust and rigorous risk management mitigation program.   Our four-step approach includes Supplier Management, Change Management, Internal Audits governed by ISO 13485:2016, and Customer Audits.


Learn More
Risk Management

Case Studies

Cell Therapy: Assurance of supply when scaling

US-based clinical stage Cell Therapy company focused on allogeneic platform needed to secure supply for Yssel’s T-Cell media to confidently meet their manufacturing scale up following positive results from their clinical development process.

Learn How GeminiBio Helped

Let’s Keep in Touch

We are committed to helping you optimize your cell culture and process liquid workflows – how can we help you?


Contact Us